Identifai-Genetics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Identifai-Genetics - overview
Established
2021
Location
Tel Aviv, -, Israel
Primary Industry
Biotechnology
About
Based in Israel and founded in 2021, idefntifAI LTD provides a clinical solution for early, non-invasive, and comprehensive prenatal genetic screening. The company was co-founded by Mr. Yossi Bornstein, Prof. Noam Shomron (CSO), Dr.
Tom Rabinowitz (CTO), and Dr. Amir Beker (CEO). In April 2023 the firm raised USD 3. 3M in post-seed funding led by eHealth Ventures, digital health VC funds, and Dr.
Ron Sabar, founder and CMO of Sabar Health. The company offers an early and comprehensive prenatal screening test for genetic syndromes through taking a blood test from the mother during the first trimester of the pregnancy. The company uses data science algorithms to provide a high-resolution picture of the fetus’s health at the early stage of the pregnancy from point mutations to chromosomal anomalies.
Current Investors
eHealth Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.identifai-genetics.com
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.